ArticleDiagnostics (Basel, Switzerland)2021
A Personalized Medical Decision Support System Based on Explainable Machine Learning Algorithms and ECC Features: Data from the Real World.
Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of Serum Fructosamine as Diagnostic Marker of Postoperative Recurrence in the Patients with Breast Cancer.BioMed research international · 2023Article
- An Adaptive Deep Ensemble Learning Method for Dynamic Evolving Diagnostic Task Scenarios.Diagnostics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Artificial intelligence can help physicians improve the accuracy of breast cancer diagnosis. However, the effectiveness of AI applications is limited by doctors' adoption of the results recommended by the personalized medical decision support system. Our primary purpose is to study the impact of external case characteristics (ECC) on the effectiveness of the personalized medical decision support system for breast cancer assisted diagnosis (PMDSS-BCAD) in making accurate recommendations. Therefore, we designed a novel comprehensive framework for case-based reasoning (CBR) that takes the impact of external features of cases into account, made use of the naive Bayes and k-nearest neighbor (KNN) algorithms (CBR-ECC), and developed a PMDSS-BCAD system by using the CBR-ECC model and external features as system components. Under the new case-based reasoning framework, the accuracy of the combined model of naive Bayes and KNN with an optimal K value of 2 is 99.40%. Moreover, in a real hospital scenario, users rated the PMDSS-BCAD system, which takes into account the external characteristics of the case, better than the original personalized system. These results suggest that PMDSS-BCD can not only provide doctors with more personalized and accurate results for auxiliary diagnosis, but also improve doctors' trust in the results, so as to encourage doctors to adopt the results recommended by the personalized system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.